Gts Securities LLC Crispr Therapeutics Ag Put Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $445,179 - $593,166	8,700 Added 13.18%	74,700 $4.03 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $2.47 Million - $3.63 Million	-40,700 Reduced 38.14%	66,000 $4.5 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $1.65 Million - $3.07 Million	42,600 Added 66.46%	106,700 $6.68 Million
Q3 2023 Nov 15, 2023	BUY	$45.39 - $59.0 $2.91 Million - $3.78 Million	64,100 New	64,100 $2.91 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.